SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Overview of attention for article published in Cardiovascular Diabetology, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter: 6 tweeters

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway

Article in Metabolism (January 2021)

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

Article in International Journal of Molecular Sciences (January 2021)

Intestinal sodium/glucose cotransporter 3 expression is epithelial and downregulated in obesity

Article in Life Sciences (December 2020)